Highly pathogenic (H5N1) avian influenza induces an inflammatory T helper type 1 cytokine response in the chicken

Journal of Interferon and Cytokine Research

Volumn 31, Issue 4, 2011, Pages 393-400

  Karpala, Adam J ^a,b   Bingham, John ^a   Schat, Karel A ^c   Chen, Li Mei ^d   Donis, Ruben O ^d   Lowenthal, John W ^a   Bean, Andrew G D ^a  

^a CSIRO   (Australia)

^b Cooperative Research Centre for the Australian Poultry Industry ^*  (Australia)

^c Department of Obstetrics Gynecology   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CHICKEN; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLUENZA A (H5N1); NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TH1 CELL; TH2 CELL; VIRUS RESISTANCE;

ANIMALS; CHICKENS; CYTOKINES; GENE EXPRESSION REGULATION, VIRAL; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; TH1 CELLS;

AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS;

EID: 79953248680     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0069     Document Type: Article

References (50)

1. Buttmann M, Merzyn C, Hofstetter HH, Rieckmann P. 2007. TRAIL, CXCL10 and CCL2 plasma levels during long-term interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response. J Neuroimmunol 190(1-2):170-176. (Pubitemid 47625614)
2. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, Willey BM, DeVries ME, Fang Y, Seneviratne C, Bosinger SE, Persad D, Wilkinson P, Greller LD, Somogyi R, Humar A, Keshavjee S, Louie M, Loeb MB, Brunton J, McGeer AJ, Kelvin DJ. 2007. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 81(16):8692-8706. (Pubitemid 47242843)
3. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, Chan YO, Chan RW, Long HT, Poon LL, Guan Y, Peiris JS. 2005. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6:135.
4. Chrousos GP. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332(20):1351-1362.
5. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12(10):1203-1207.
6. Del Prete G. 1998. The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 16(3-4):427-455. (Pubitemid 28102263)
7. Donelan NR, Basler CF, Garcia-Sastre A. 2003. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77(24):13257-13266. (Pubitemid 37494321)
8. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252(2):324-330. (Pubitemid 29013414)
9. Giannessi D, Colotti C, Maltinti M, Del Ry S, Prontera C, Turchi S, Labbate A, Neglia D. 2007. Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones 12(3):265-274. (Pubitemid 351199389)
10. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101(3):643-649. (Pubitemid 28084248)
11. Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, Weidmann M, Casanova JL, Haller O, Kochs G. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 81(14):7776-7785. (Pubitemid 47047864)
12. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. 2005. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307(5708):430-433. (Pubitemid 40139989)
13. Julkunen I, Melen K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. 2000. Inflammatory responses in influenza A virus infection. Vaccine 19 (Suppl. 1):S32-S37. (Pubitemid 32121717)
14. Jura J, Wegrzyn P, Korostynski M, Guzik K, Oczko-Wojciechowska M, Jarzab M, Kowalska M, Piechota M, Przewlocki R, Koj A. 2008. Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays. Biochim Biophys Acta 1779(6-7):383-389. (Pubitemid 351847863)
15. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG. 2001. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 64(3):262-268. (Pubitemid 32565121)
16. Karpala AJ, Lowenthal JW, Bean AG. 2008a. Activation of the TLR3 pathway regulates IFNbeta production in chickens. Dev Comp Immunol 32(4):435-444.
17. Karpala AJ, Morris KR, Broadway MM, McWaters PG, O'Neil TE, Goossens KE, Lowenthal JW, Bean AG. 2008b. Molecular cloning, expression, and characterization of chicken IFN-lambda. J Interferon Cytokine Res 28(6):341-350. (Pubitemid 351929936)
18. Katz JM, Lu X, Frace AM, Morken T, Zaki SR, Tumpey TM. 2000. Pathogenesis of and immunity to avian influenza A H5 viruses. Biomed Pharmacother 54(4):178-187. (Pubitemid 30350568)
19. Katze MG, He Y, Gale M Jr. 2002. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2(9):675-687. (Pubitemid 37328725)
20. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, Feldmann F, Alimonti JB, Fernando L, Li Y, Katze MG, Feldmann H, Kawaoka Y. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445(7125):319-323. (Pubitemid 46122819)
21. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368(6469):339-342. (Pubitemid 24104268)
22. Lienenluke B, Christ B. 2007. Impact of interleukin-6 on the glucose metabolic capacity in rat liver. Histochem Cell Biol 128(4):371-377. (Pubitemid 47415783)
23. Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. 2007. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115(4):45-56. (Pubitemid 46376171)
24. Munder M, Mallo M, Eichmann K, Modolell M. 1998. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 187(12):2103-2108. (Pubitemid 28285581)
25. Nagai T, Devergne O, Mueller TF, Perkins DL, van Seventer JM, van Seventer GA. 2003. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J Immunol 171(10):5233-5243. (Pubitemid 37432808)
26. Nawijn MC, Dingjan GM, Ferreira R, Lambrecht BN, Karis A, Grosveld F, Savelkoul H, Hendriks RW. 2001. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo. J Immunol 167(2):724-732. (Pubitemid 32660825)
27. O'Shea JJ, Paul WE. 2002. Regulation of T(H)1 differentiation - controlling the controllers. Nat Immunol 3(6):506-508. (Pubitemid 34662299)
28. Osterlund P, Veckman V, Siren J, Klucher KM, Hiscott J, Matikainen S, Julkunen I. 2005. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 79(15):9608-9617. (Pubitemid 41022304)
29. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y. 2004. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363(9409):617-619. (Pubitemid 38264181)
30. Perkins LE, Swayne DE. 2001. Pathobiology of A/chicken/Hong Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Vet Pathol 38(2):149-164. (Pubitemid 33621690)
31. Ruschpler P, Stiehl P. 2002. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA). Cell Mol Biol (Noisy-Le-Grand) 48(3):285-293.
32. Salomon R, Hoffmann E, Webster RG. 2007. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A 104(30):12479-12481. (Pubitemid 47206163)
33. Sareneva T, Matikainen S, Kurimoto M, Julkunen I. 1998. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol 160(12):6032-6038. (Pubitemid 28298066)
34. Scholtissek C. 1995. Molecular evolution of influenza viruses. Virus Genes 11(2-3):209-215. (Pubitemid 26186012)
35. Sinigaglia F, D'Ambrosio D, Rogge L. 1999. Type I interferons and the Th1/Th2 paradigm. Dev Comp Immunol 23(7-8):657-663. (Pubitemid 29509755)
36. Skoner DP, Gentile DA, Patel A, Doyle WJ. 1999. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis 180(1):10-14. (Pubitemid 29293911)
37. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67(1):227-264. (Pubitemid 28411130)
38. Suzuki K, Okada H, Itoh T, Tada T, Mase M, Nakamura K, Kubo M, Tsukamoto K. 2009. Association of increased pathogenicity of Asian H5N1 highly pathogenic avian influenza viruses in chickens with highly efficient viral replication accompanied by early destruction of innate immune responses. J Virol 83(15):7475-7486.
39. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V. 2008. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 376(1):53-59.
40. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, Sambhara S, Tumpey TM, Katz JM. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 81(6):2736-2744. (Pubitemid 46447038)
41. To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, Tang NL, Tsang DN, Sung RY, Buckley TA, Tam JS, Cheng AF. 2001. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63(3):242-246. (Pubitemid 32116480)
42. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3(2):133-146. (Pubitemid 37328691)
43. Van Der Sluijs KF, Van Elden LJ, Arens R, Nijhuis M, Schuurman R, Florquin S, Kwakkel J, Akira S, Jansen HM, Lutter R, Van Der Polls T. 2005. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus. Immunology 114(1):112-120. (Pubitemid 40030299)
44. Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74(24):11566-11573. (Pubitemid 32222305)
45. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14(5):361-368. (Pubitemid 37099449)
46. Weber J, Yang JC, Topalian SL, Parkinson DR, Schwartzentruber DS, Ettinghausen SE, Gunn H, Mixon A, Kim H, Cole D, and others. 1993. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 11(3):499-506.
47. Williams BR. 1999. PKR; a sentinel kinase for cellular stress. Oncogene 18(45):6112-6120.
48. Wohlleben G, Erb KJ. 2004. The absence of IFN-gamma leads to increased Th2 responses after influenza A virus infection characterized by an increase in CD4+ but not CD8+ T cells producing IL-4 or IL-5 in the lung. Immunol Lett 95(2):161-166. (Pubitemid 39237661)
49. Zeng H, Goldsmith C, Thawatsupha P, Chittaganpitch M, Waicharoen S, Zaki S, Tumpey TM, Katz JM. 2007. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J Virol 81(22):12439-12449. (Pubitemid 350085857)
50. Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, Wang Q, Killeen N, Urban JF Jr., Guo L, Paul WE. 2004. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol 5(11):1157-1165. (Pubitemid 39549630)